ASTRAZENECA LATEST PATENTS

Latest patents of Astrazeneca published after 2022 at the EPO

Patent Number Title Grant Date Activity Alert
EP2508188B1 Pharmaceutical Formulations Containing Dapagliflozin Propylene Glycol Hydrate 10 May, 2023
EP3769781B1 Stable Anti-Ifnar1 Formulation 19 Apr, 2023
EP2785349B2 Combination Treatment Of Cancer 09 Nov, 2022
EP3935060A1 Fused tricyclic compounds useful as anticancer agents 12 Jan, 2022